Results 141 to 150 of about 7,521 (213)

Impact of PC/BCP Mutations on Seroconversion and Relapse in HBeAg-Positive Chronic Hepatitis B Patients Treated with Nucleoside Analogues. [PDF]

Infect Drug Resist
Xia S, He X, Gan J, Ding J.
europepmc   +1 more source

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France [PDF]

, 2016

core   +1 more source

Genotype-specific Response to 144-week Entecavir Therapy for HBeAg-positive Chronic Hepatitis B with a Particular Focus on Histological Improvement: A Prospective Study. [PDF]

J Clin Transl Hepatol
Liu L, Xu Q, Lin S, Wei Z, Huang G.
europepmc   +1 more source

Management Of Patients With Hepatitis B Virus Reactivation Post-DAA Treatment Of Chronic Hepatitis C Virus Infection In HCV-HBV Coinfected Patients With Pretreatment HBeAg Seroconversion And Early Degree Of Hepatic Fibrosis. [PDF]

Infect Drug Resist, 2019
Osman HA, Ghweil AA, Sabry AM, Mahdy RE, Khodeary A.   +4 more
europepmc   +1 more source

Traditional and Novel Virologic Markers for Functional Cure and HBeAg Loss with Pegylated Interferon in Chronic Hepatitis B: A Systematic Review and Meta-analysis. [PDF]

J Clin Transl Hepatol
Zhang Y, Wang LF, Chen J, Nguyen MH, Zheng Q.   +4 more
europepmc   +1 more source

Dades epidemiològiques, clíniques i tractament de pacients amb infecció crònica pel virus hepatitis b en l'àrea barcelonès nord i maresme [PDF]

, 2013
Morillas Cunill, Rosa Ma., Planas Vilà, Ramon, Riu Pons, Fausto, Universitat Autònoma de Barcelona. Departament de Medicina, Universitat Autònoma de Barcelona. Facultat de Medicina   +4 more
core  

HBsAg plasma level kinetics:a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy [PDF]

, 2015
Bansal, S, Bruce, M, Carey, I, D'Antiga, L, Horner, M, Mieli-Vergani, G, Vergani, D, Zen, Y   +7 more
core   +1 more source

Association between fatty liver and risk of liver failure in patients with acute hepatitis B: a retrospective cohort study. [PDF]

Front Cell Infect Microbiol
Wang XH, Chang YN, Zhang L, Yang YL, Liang LW, Zeng Y, Zhou Z, Zhong S, Li H.   +8 more
europepmc   +1 more source

Correction for Suzuki et al., "Evaluation of fully automated chemiluminescent enzyme immunoassays for hepatitis B core-related antigen components, phosphorylated and non-phosphorylated hepatitis B core antigens: clinical significance and dynamics during hepatitis B e antigen seroconversion". [PDF]

J Clin Microbiol
Suzuki T, Ohue C, Arai O, Inose Y, Nagaoka K, Ogawa S, Inoue T, Matsuura K, Aoyagi K, Yagi S, Tanaka Y.   +10 more
europepmc   +1 more source

Pegylated Interferon-α-Induced Functional Cure for Special Populations with Chronic Hepatitis B Virus Infection: Current Trends, Challenges and Prospection. [PDF]

Drug Des Devel Ther
Zhang Y, Li Y, Lian JQ, Kang W.
europepmc   +1 more source